Pinnacle Associates LTD Moderna, Inc. Transaction History

Pinnacle Associates LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	SELL	$96.41 - $126.61 $10,123 - $13,294	-105 Reduced 3.52%	2,880 $297,000
Q2 2023 Jul 26, 2023	BUY	$118.5 - $160.53 $41,001 - $55,543	346 Added 13.11%	2,985 $362,000
Q1 2023 May 04, 2023	SELL	$135.66 - $197.02 $15,058 - $21,869	-111 Reduced 4.04%	2,639 $405,000
Q4 2022 Jan 31, 2023	SELL	$118.38 - $210.04 $28,647 - $50,829	-242 Reduced 8.09%	2,750 $493,000
Q4 2022 Jan 25, 2023	SELL	$118.38 - $210.04 $7,694 - $13,652	-65 Reduced 2.13%	2,992 $0
Q3 2022 Oct 31, 2022	BUY	$118.07 - $194.18 $65,174 - $107,187	552 Added 22.04%	3,057 $361,000
Q2 2022 Aug 02, 2022	SELL	$117.13 - $176.59 $30,219 - $45,560	-258 Reduced 9.34%	2,505 $358,000
Q1 2022 May 05, 2022	BUY	$126.46 - $235.05 $29,085 - $54,061	230 Added 9.08%	2,763 $476,000
Q4 2021 Feb 02, 2022	BUY	$225.82 - $368.51 $154,009 - $251,323	682 Added 36.84%	2,533 $643,000
Q3 2021 Oct 19, 2021	BUY	$221.9 - $484.47 $26,628 - $58,136	120 Added 6.93%	1,851 $712,000
Q2 2021 Aug 02, 2021	BUY	$129.91 - $234.98 $224,874 - $406,750	1,731 New	1,731 $407,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

Stay updated on Pinnacle Associates LTD with notifications on news.